EPA Superfund Site
CURTIS SPECIALTY PAPERS, INC
NJ | EPA ID NJD057143984
About this site’s exposure pathways:
There is insufficient information to determine the site-wide Human Exposure Control status at the Curtis Specialty Papers site. Polychlorinated biphenyls (PCBs) have been detected in soils and sediments at numerous locations on the Site. Potential human exposure pathways include dermal contact with and incidental ingestion of PCB-contaminated soils and sediments and ingestion of PCB-contaminated fish tissue. Sediments of Quequacommisacong Creek are contaminated with PCBs at locations where anglers catch fish for human consumption. PCBs cause cancer in animals and probably cause cancer in humans (B2 classification or "likely to cause cancer in humans"). Other long-term adverse health effects of PCBs observed in laboratory animals include a reduced ability to fight infections, low birth weights, and learning problems.
Asbestos-containing material (ACM) is also present at the Site. Buildings have been scavenged and vandalized, resulting in extensive damage to ACM and presumed asbestos containing material (PACM), both inside and outside of the buildings. Persons accessing the Site could become exposed to asbestos and could carry the fibers home in their clothing and hair, exposing others. Asbestos exposure can cause the chronic medical condition known as asbestosis, which is a progressive scarring of lung tissue and associated difficulty breathing, and two types of cancer: lung tissue cancer and mesothelioma, which is cancer of the protective membrane that surrounds the lung and other internal organs.
EPA ensures community participation throughout the remedial process by meeting with residents and affected stakeholders, issuing public notices and updating fact sheets. A site profile has been established on the EPA website to keep the community informed of recent progress at the site. Additionally, an EPA Community Involvement Coordinator is assigned to the site and can address specific community concerns as they arise.